Theriva Biologics Inc had a pretty Dodgy run when it comes to the market performance. Over the past year, the company’s stock reached a high of $17.11 on 03/20/24, while the lowest price during the same period was $1.24 on 10/02/24.
52-week price history of TOVX Stock
A stock’s 52-week high and low prices can reveal a great deal about its present condition and potential future performance. Theriva Biologics Inc’s current trading price is -88.49% away from its 52-week high, while its distance from the 52-week low is 58.87%. The stock’s price range during this period has fluctuated between $1.24 and $17.11. Shares of the company, which operates in the Healthcare sector, recorded a trading volume of around 0.99 million for the day, which was evidently lower than the average daily volume of 3.32 million over the last three months.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Financial Performance and Market Capitalization
Theriva Biologics Inc (TOVX) has experienced a quarterly decline of -62.06% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 4.47M and boasts a workforce of 22 employees.
Moving average and trading volume data
Based on Barchart.com data, the company’s moving average over the 100-day period was 4.13, with a change in price of -4.06. Similarly, Theriva Biologics Inc recorded 2,172,715 in trading volume during the last 100 days, posting a change of -67.30%.
TOVX Debt-to-equity ratio analysis
The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for TOVX stands at 0.07. Similarly, the long-term debt-to-equity ratio is also 0.05.
TOVX Stock Stochastic Average
Theriva Biologics Inc’s raw stochastic average for the past 50 days is currently at 12.35%. This represents a fall from the raw stochastic average of the last 20 days, which was recorded at 49.24%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 52.27% and 45.00%, respectively.
TOVX Stock Price Performance Analysis
The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. Year to date metric has recorded a loss of -81.68%.However, over the last six months, we can see a stronger performance of -81.15%. Over the last 30 days, the price of TOVX has fallen by 20.86%. And in the last five days, it has surged by 34.01%.
